183 related articles for article (PubMed ID: 10722027)
1. Papillary thyroid carcinoma: prognostic index for survival including the histological variety.
Sebastian SO; Gonzalez JM; Paricio PP; Perez JS; Flores DP; Madrona AP; Romero PR; Tebar FJ
Arch Surg; 2000 Mar; 135(3):272-7. PubMed ID: 10722027
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
[TBL] [Abstract][Full Text] [Related]
3. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
4. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract][Full Text] [Related]
5. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
[TBL] [Abstract][Full Text] [Related]
6. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.
Verburg FA; Mäder U; Luster M; Reiners C
Eur J Endocrinol; 2009 Apr; 160(4):619-24. PubMed ID: 19158232
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma.
Jung TS; Kim TY; Kim KW; Oh YL; Park DJ; Cho BY; Shong YK; Kim WB; Park YJ; Jung JH; Chung JH
Endocr J; 2007 Apr; 54(2):265-74. PubMed ID: 17379963
[TBL] [Abstract][Full Text] [Related]
8. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
9. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
11. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.
Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A
World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709
[TBL] [Abstract][Full Text] [Related]
13. MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.
Dai L; Wang Y; Chen L; Zheng J; Li J; Wu X
World J Surg Oncol; 2017 Jan; 15(1):11. PubMed ID: 28061868
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas.
Woo CG; Sung CO; Choi YM; Kim WG; Kim TY; Shong YK; Kim WB; Hong SJ; Song DE
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S728-33. PubMed ID: 26077913
[TBL] [Abstract][Full Text] [Related]
16. Extent of surgery affects survival for papillary thyroid cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS; Sturgeon C
Ann Surg; 2007 Sep; 246(3):375-81; discussion 381-4. PubMed ID: 17717441
[TBL] [Abstract][Full Text] [Related]
17. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
18. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
19. Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study.
Ortiz S; Rodríguez JM; Soria T; Pérez-Flores D; Piñero A; Moreno J; Parrilla P
Otolaryngol Head Neck Surg; 2001 Mar; 124(3):261-5. PubMed ID: 11240987
[TBL] [Abstract][Full Text] [Related]
20. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
